نتائج البحث

Profiling of five urinary exosomal miRNAs for the differential diagnosis of patients with diabetic kidney disease and focal segmental glomerulosclerosis.

• Authors : Trabulus, Sinan¹ (AUTHOR) ; Zor, Mehmet Seyit^2,3 (AUTHOR); Alagoz, Selma⁴ (AUTHOR)

Subjects: *FOCAL segmental glomerulosclerosis; *KIDNEY diseases; *MICRORNA

• Source: PLoS ONE. 10/29/2024, Vol. 19 Issue 10, p1-10. 10p.

تفاصيل العنوان

Identification of Pathogenic Pathways for Recurrence of Focal Segmental Glomerulosclerosis after Kidney Transplantation.

• Authors : Pajenda, Sahra¹ (AUTHOR) ; Gerges, Daniela¹ (AUTHOR) ; Wagner, Ludwig¹ (AUTHOR)

• Source: Diagnostics (2075-4418). Aug2024, Vol. 14 Issue 15, p1591. 15p.

تفاصيل العنوان

Safety and Biodistribution of an Autologous Bone Marrow‐Derived Mononuclear Cell Infusion into Renal Arteries in Patients with Focal Segmental Glomerulosclerosis: A Phase 1 Study.

• Authors : Botelho, Bruno Freire¹ (AUTHOR); Barreira, André Luis¹ (AUTHOR); Filippo, Marcio Gomes² (AUTHOR)

• Source: Stem Cells International. 7/9/2024, Vol. 2024, p1-11. 11p.

تفاصيل العنوان

Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis

• Source: An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental GlomerulosclerosisGaleano B, Klootwijk R, Manoli I, Sun M,

تفاصيل العنوان

Genetic Markers for Focal Segmental Glomerulosclerosis

• Source: Genetic Markers for Focal Segmental Glomerulosclerosis

تفاصيل العنوان

Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis

• Source: A Phase II, Multi-center, Open-Label Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of R3R01 in AS Patients With Uncontrolled Proteinuria on ACE/ARB Inhibition and in Patients

تفاصيل العنوان

A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis

• Source: A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of BI 764198 Administered

تفاصيل العنوان

A Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease (RESULT)

• Source: A Parallel-group Treatment, Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Umbrella Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, and Rilzabrutinib in

تفاصيل العنوان

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children (FSGS pediatric)

• Source: Treatment of Drug-resistant Pediatric Primary Focal Segmental Glomerulosclerosis Using the Liposorber® LA-15 SystemReidy K, Kaskel FJ. Pathophysiology of focal

تفاصيل العنوان

Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

• Authors : Zubin Juzer Modi, Assistant Professor of Pediatrics, Division of Nephrology

• Source: Precision Medicine Proof of Concept for Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

تفاصيل العنوان